The Study of Recombinant Human Granulocyte Colony-Stimulating Factor in the Treatment of Ishemic Cerebral Infarction in Rat

刘娜,张俊,陈大方,樊东升,张琳
DOI: https://doi.org/10.3969/j.issn.0253-9713.2007.01.001
2007-01-01
Abstract:Objective To explore whether recombinant human granulocyte colony-stimulating factor(rhG-CSF) can be used to treat ischemic cerebral infarction in rats and the time for treatment. Methods Rat cerebral infarction model was established by line occlusion. The rats received rhG-CSF(50 μg/kg, subcutaneously) or vehicle(saline) at 1 hour and 6 hours after ischemia. The technique of TTC staining was used to detect the volume of infarction. Results The infarction volume of the rat brain was smaller in the two rhG-CSF therapy groups than the two control groups 48 hours later(P0.01). There was no difference between the two treatment groups. Conclusions rhG-CSF can relieve the degree of ischemia and reduce the infarction volume. The efficacy of treating at 6 hours after ischemia is the same as treating at 1hour after ischemia.
What problem does this paper attempt to address?